Cargando…

Using serological data to understand unobserved SARS-CoV-2 risk in health-care settings

Detalles Bibliográficos
Autores principales:	Kucharski, Adam J, Nilles, Eric J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398653/ https://www.ncbi.nlm.nih.gov/pubmed/32758436 http://dx.doi.org/10.1016/S1473-3099(20)30579-X

Ejemplares similares

The complexities of SARS-CoV-2 serology
por: Houlihan, Catherine F, et al.
Publicado: (2020)

Tracking SARS-CoV-2 infection in India with serology
por: John, Jacob, et al.
Publicado: (2021)

Population serology for SARS-CoV-2 is essential to regional and global preparedness
por: Tian, Huaiyu, et al.
Publicado: (2020)

Understanding the drivers of transmission of SARS-CoV-2
por: Cornelissen, Laura, et al.
Publicado: (2021)

Travel measures in the SARS-CoV-2 variant era need clear objectives
por: Kucharski, Adam J, et al.
Publicado: (2022)

Estimating unobserved SARS-CoV-2 infections in the United States
por: Perkins, T. Alex, et al.
Publicado: (2020)

Understanding SARS-CoV-2-related multisystem inflammatory syndrome in children
por: Rowley, Anne H.
Publicado: (2020)

The immune system of children: the key to understanding SARS-CoV-2 susceptibility?
por: Carsetti, Rita, et al.
Publicado: (2020)

SARS-CoV-2 reinfection in a closed setting: lessons for the community
por: Velasco, María, et al.
Publicado: (2021)

A33 Using serological and surveillance data to infer the introduction date and unobserved transmission dynamics of Zika virus in Fiji 2013–7
por: Henderson, A, et al.
Publicado: (2019)

Understanding how fast SARS-CoV-2 variants transmit from household studies
por: Yang, Yang, et al.
Publicado: (2022)

Importance of precise data on SARS-CoV-2 transmission dynamics control
por: Rybniker, Jan, et al.
Publicado: (2020)

Immunosuppression and SARS-CoV-2 breakthrough infections
por: Kim, Alfred H J, et al.
Publicado: (2022)

Asymptomatic SARS-CoV-2 infection
por: Ooi, Eng Eong, et al.
Publicado: (2020)

Neonatal SARS-CoV-2 infection
por: de Carvalho, Werther Brunow, et al.
Publicado: (2020)

Towards SARS-CoV-2 serotypes?
por: Simon-Loriere, Etienne, et al.
Publicado: (2022)

Assessing the potential for fomite transmission of SARS-CoV-2
por: Short, Kirsty R, et al.
Publicado: (2023)

SARS-CoV-2 testing for public health use: core principles and considerations for defined use settings
por: Boehme, Catharina, et al.
Publicado: (2021)

Bell's palsy and SARS-CoV-2 vaccines
por: Ozonoff, Al, et al.
Publicado: (2021)

SARS-CoV-2 vaccination in people with HIV
por: Spinelli, Matthew A
Publicado: (2021)

Optimising SARS-CoV-2 vaccination schedules
por: Belda-Iniesta, Cristobal
Publicado: (2021)

The SARS-CoV2 pandemic and routine immunisation
por: Kang, Gagandeep
Publicado: (2022)

Sustainability of surveillance systems for SARS-CoV-2
por: Adlhoch, Cornelia, et al.
Publicado: (2022)

Antibodies, epicenter of SARS-CoV-2 immunology
por: Pecetta, Simone, et al.
Publicado: (2021)

Decoding the next SARS-CoV-2 variant
por: Nel, Jeremy, et al.
Publicado: (2022)

Diabetes after SARS-CoV-2 infection
por: Al-Aly, Ziyad
Publicado: (2023)

SARS-CoV-2 infection and cardiac arrhythmias
por: Dewland, Thomas A., et al.
Publicado: (2022)

SARS-CoV-2 rebound with and without antivirals
por: Petrosillo, Nicola
Publicado: (2023)

Endemic SARS-CoV-2 will maintain post-pandemic immunity
por: Veldhoen, Marc, et al.
Publicado: (2021)

Risk of SARS-CoV-2 reinfection after natural infection
por: Boyton, Rosemary J, et al.
Publicado: (2021)

How outbreaks in different settings contribute to the transmission of SARS-CoV-2 in the era of “living with COVID”: the case of Japan
por: Leung, Char, et al.
Publicado: (2023)

SARS-Cov-2 immune waning and reinfection in care-home settings
por: Altmann, Daniel M, et al.
Publicado: (2021)

Association of SARS-CoV-2 infection and persistence with long COVID
por: Yang, Chengliang, et al.
Publicado: (2023)

WHO international standard for SARS-CoV-2 antibodies to determine markers of protection
por: Zhu, Feng, et al.
Publicado: (2022)

Serological Markers of SARS-CoV-2 Reinfection
por: Siddiqui, Sameed M., et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence in COVID-19 hotspots
por: Eckerle, Isabella, et al.
Publicado: (2020)

Impact of contact tracing on SARS-CoV-2 transmission
por: Sun, Kaiyuan, et al.
Publicado: (2020)

Who is most likely to be infected with SARS-CoV-2?
por: Jordan, Rachel E, et al.
Publicado: (2020)

SARS-CoV-2: virus dynamics and host response
por: Chen, Yu, et al.
Publicado: (2020)

Persistence of IgG response to SARS-CoV-2
por: Duysburgh, Els, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2n53h30j3gui2rea6pf4tnaq6f